Effect of asymmetric modification on the conformation of ascidiacyclamide analogs

Journal of Peptide Research

Volumn 60, Issue 1, 2002, Pages 10-22

  Asano, A ^a   Minoura, K ^a   Yamada, T ^a   Numata, A ^a   Ishida, T ^a   Doi, M ^a   Katsuya, Y ^b   Mezaki, Y ^b   Sasaki, M ^c   Taniguchi, T ^c   Nakai, M ^c   Hasegawa, H ^c   Terashima, A ^c  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Hyogo Prefectural Institute of Industrial Research Technical Center for Machinery and Metals   (Japan)

^c Hyogo Institute for Aging Brain and Cognitive Disorders   (Japan)

Author keywords

1H NMR; Ascidian; Circular dichroism; Cyclic peptide; Cytotoxic; Molecular folding; Patellamide; X ray diffraction structure

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; ALANINE; ASCIDIACYCLAMIDE; DIMETHYL SULFOXIDE; GLYCINE; ISOLEUCINE; LEUCINE; OXAZOLINE DERIVATIVE; PHENYLALANINE; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID COMPOSITION; AMINO ACID SUBSTITUTION; ARTICLE; CIRCULAR DICHROISM; CRYSTAL STRUCTURE; CYTOTOXICITY TEST; LEUKEMIA P 388; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPERATURE DEPENDENCE; TITRIMETRY; X RAY DIFFRACTION;

AMINO ACID SUBSTITUTION; ANIMALS; ANTINEOPLASTIC AGENTS; CIRCULAR DICHROISM; CRYSTALLOGRAPHY, X-RAY; DIMETHYL SULFOXIDE; LEUKEMIA P388; LEUKEMIA, LYMPHOCYTIC; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; PEPTIDES, CYCLIC; SOLVENTS; TEMPERATURE; TUMOR CELLS, CULTURED;

ASCIDIA; GOSSYPIUM HIRSUTUM;

EID: 0036085670     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.2002.02981.x     Document Type: Article

References (35)

1. A new cyclic peptide, ascidiacyclamide, isolated from ascidian
2. Ulicyclamide and ulithiacyclamide, two new small peptides from a marine tunicate
3. Antineoplastic cyclic peptide from marine tunicate Lissoclinum patella
4. Absolute configuration of thiazole amino acids in peptides
5. Cyclic peptide structures from tunicate Lissoclinum patella by FAB mass spectrometry
6. cis, cis- and trans, trans-ceratospongamide, new bioactive cyclic heptapeptides from the Indonesian red alga Ceratodictyon spongiosum and symbiotic sponge Sigmadocia symbiotica
7. X-Ray crystal structure of ascidiacyclamide, a cytotoxic cyclic peptide from Ascidian
8. Solution and solid-state conformations of ascidiacyclamide, a cytotoxic cyclic peptide from Ascidian
9. Cyclic peptides from the ascidian Lissoclinum patella: Conformational analysis of patellamide D by X-ray analysis and molecular modeling
10. Molecular conformation of ascidiacyclamide, a cytotoxic cyclic peptide from ascidian: X-ray analyses of its free form and solvate crystals
11. Molecular conformation of patellamide A, a cytotoxic cyclic peptide from the ascidian Lissoclinum patella, by X-ray crystal analysis
12. Conformational change of ascidiacyclamide caused by asymmetric modification for an isoleucine residue: Structural analyses of [Gly], [Leu], and [Phe]ascidiacyclamides by x-ray diffraction and NMR spectroscopy
13. 2, cyclo(-Ala-aThr-D-Val-Thz-Ile-aThr-D-Val-Thz-), cyclo(-Val-aThr-D-Val-Thz-Ile-aThr-D-Val-Thz-), and cyclo(-Ile-aThr-Val-Thz-Ile-aThr-D-Val-Thz-)
14. A β-sheet structure formed by C-H...O hydrogen bonds between the thiazole rings and amide bonds of a dimeric desoxazoline ascidiacyclamide analogue
15. A folded conformation of an ascidiacyclamide derivative: 3-methoxysulfoxide-(2R,3R]-threoninyl desoxazoline-ascidiacyclamide
16. Total syntheses and re-assignment of configurations of the cyclopeptides lissoclinamide 4 and lissoclinamide 5 from Lissoclinum patella
17. Total synthesis and assignment of configuration of the thiazoline-based cyclodidemnamide isolated from the sea squirt Didemnum molle
18. New methods and reagents in organic synthesis. 51. A synthesis of ascidiacyclamide, a cytotoxic peptide from ascidian - Determination of its absolute configuration
19. New methods and reagents in organic synthesis. 67. A general synthesis of derivatives of optically pure 2-(1-aminoalkyl) thiazole-4-carboxylic acids
20. Integration of macromolecular diffraction data
21. The CCP4 Suite: Programs for protein crystallography
22. Mechanistic aspects of the cytocidal action of ulithiacyclamide on mouse leukemia L1210 cells in vitro
23. Ulicyclamide is cytotoxic against L1210 cell in vitro and inhibits both DNA and RNA syntheses
24. Structure of ascidiacyclamide as the ethanol water solvate, a cytotoxic cyclic peptide from Ascidian
25. Conformations of cyclic peptides. IV. Nuclear magnetic resonance studies of cyclo-pentaglycyl-1-leucyl and cyclo-diglycyl-1-histidyldiglycyl-1-tyrosyl
26. Conformational and ion binding studies of a cyclic pentapeptide. Evidence for β- and γ-turns in solution
27. Trifluoroethanol may form a solvent matrix for assisted hydrophobic interactions between peptide side chains
28. Does trifluoroethanol affect folding pathways and can it be used as a probe of structure in transition states?
29. A new 2,2,2-trifluoroethanol model for molecular dynamics simulations
30. Protein folding transition states: Elicitation of Hammond effects by 2,2,2-trifluoroethanol
31. Properties of 2,2,2-trifluoroethanol and water mixtures
32. Relationship between the tertiary structure os of mastropam B and its analogs and their lyric activities studied by NMR spectroscopy